Joey CohenMedication Adherence
Frank BurrellScientific Storytelling
Matthew DurhamOmnidynamic Marketing
Bud BilanichSuccess Coach
Liz KaneImpactful Strategy
David LinetskyPoint-of-Care Marketing
Daniel SontupeMarket Access
Pat PurcellMeeting Engagement
Suma Ramadas, PhDMedical Affairs
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Matt TurnerPatient Affordability
Amy GilesIncreasing Engagement
Brenda SnowAuthentic Patient Voice
HACKENSACK, N.J., June 22, 2017 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of ...
– 91% CR+CRi/CRp Rate in Ivosidenib-treated Patients with De Novo AML and 53% in Ivosidenib-treated ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email